Stenocare A/S (STENO.CO) Stock Price

Stenocare A/S Price

OMX·CLOSED
0.78
​
Market closed

Revenue has compounded at 7.8% per year over the past 7 years to 7.02 M DKK. Stenocare A/S's net margin stands at -34.0%, up from -808.4% several years earlier.

Stenocare A/S stock price

Access this data via the Eulerpool API

Stenocare A/S business model & stock analysis

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

Frequently asked questions about Stenocare A/S

Converted at the current exchange rate, the Stenocare A/S share trades at 0.10 EUR (0.78 DKK).

The Stenocare A/S share (STENO.CO) is listed on 4 stock exchanges, including: Frankfurt (S7C.F), München (S7C.MU), Kopenhagen (STENO.CO).

The expected revenue of Stenocare A/S is 16.50 M DKK. This figure is based on current financial data and reflects the company's business performance.

The profit cannot currently be calculated for Stenocare A/S.

The P/E ratio cannot be calculated for Stenocare A/S at the moment.

The price-to-sales ratio (P/S) of Stenocare A/S is currently 1.97. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Stenocare A/S stock.

The Eulerpool Quality Score for Stenocare A/S is 2/10.

The ISIN of Stenocare A/S is DK0061078425. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Stenocare A/S is A2N6HF. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Stenocare A/S is STENO.CO. The ticker symbol is used to trade Stenocare A/S shares on the stock exchange.

Fair ValueTerminal
0.66 DKK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website stenocare.dk
Country
Denmark
Currency
DKK
Initial public offering
Oct 26, 2018
ISIN
DK0061078425
Cusip
K9251L116
Market capitalization
33.85 M DKKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/Ee 2027
—
P/Ee 2028
7.80
P/S
P/Se
1.97
EV/EBIT
—
P/B Ratio
3.57
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-20.86 %
Last updated Oct 11, 2026, 1:47 PM

Stenocare A/S Peer Group

Stenocare A/S Ticker

COPENHAGEN · STENO.COCOPENHAGEN · STENO.COFRANKFURT · S7C.FMUNICH · S7C.MU

Stenocare A/S FIGI

S7C:GR · BBG00MCL3FW9S7C:GF · BBG00MCL3FX8S7C:GM · BBG00MCL3G20S7C:GB · BBG00MCL3G39STENO:DF · BBG00TSV4M22

All fundamentals and in-depth analysis of Stenocare A/S

Our stock analysis for Stenocare A/S stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stenocare A/S. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.